humanitarian
Archived signal Translated · Español · 2–5m lag
Medicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Zolsketil, doxorubicina pegilada, Fecha de autorización: 31/05/2022, Revisión: 5, Estado: Autorizado
Medicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Ahzantive, Aflibercept, Fecha de autorización: 13/01/2025, Revisión: 6, Estado: Autorizado
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Zolsketil, doxorubicina pegilada, Fecha de autorización: 31/05/2022, Revisión: 5, Estado: AutorizadoEMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Zolsketil, doxorubicina pegilada, Fecha de autorización: 31/05/2022, Revisión: 5, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised1 recorded state
Signal first indexedP2 · 99% quality · 2 sources